Key result
Temporary transvenous pacing using a novel 3.5 Fr active-fixation lead from the femoral approach resulted in a low dislocation rate of 4.8% and a total complication rate of 31%.
Why the study?
Does a novel 3.5 Fr active-fixation temporary pacing lead reduce dislocation rates and improve safety in patients requiring prolonged temporary pacing?
Observational (n=42)
Does a novel 3.5 Fr active-fixation temporary pacing lead reduce dislocation rates and improve safety in patients requiring prolonged temporary pacing?
The use of a 3.5 Fr active-fixation lead for temporary transvenous pacing via the femoral approach is safe and associated with a low dislocation rate of 4.8%, permitting long-term ambulatory pacing.
Hypothesis-generating for femoral active-fixation temporary pacing; does not yet support routine adoption pending controlled trials.
DE COCK, C.C., et al .: Usefulness of a New Active‐Fixation Lead in Transvenous Temporary Pacing from the Femoral Approach. Temporary transvenous pacing is associated with a high incidence of complications with a substantial dislocation rate reported to occur in more than one‐third of patients. This article describes a novel 3.5 Fr temporary pacing lead using active fixation in a consecutive series of 42 patients with prolonged (≥48 hours) temporary pacing. The dislocation rate was 4.8%, while in 7.1% of patients inappropriate pacing (more than a twofold increase of initial pacing threshold) was observed. The total procedural related complication rate (dislocation, inappropriate pacing, local infection, and/or thrombosis) was 31% during a mean duration of pacing of 5.96 ± 2.6 days . Ambulatory pacing was performed in the vast majority (74%) of patients. Temporary transvenous pacing using an active‐fixation lead is safe and permits long‐term ambulatory pacing with a low dislocation rate.(PACE 2003; 26[Pt. I]:849–852)
No takes yet. Share an insight, caveat, or question.
Cock et al. (2003) conducted an observational in Prolonged temporary pacing (n=42). 3.5 Fr temporary pacing lead using active fixation was evaluated on Dislocation rate. Temporary transvenous pacing using a novel 3.5 Fr active-fixation lead from the femoral approach resulted in a low dislocation rate of 4.8% and a total complication rate of 31%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: